Investigation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of a Long-Acting α-MSH Analog in Healthy Overweight and Obese Subjects

MC4-NN2-0453 is a novel, long-acting, selective, melanocortin-4-receptor agonist developed for treatment of obesity. This first-human-dose, randomized, double-blind, placebo-controlled trial investigated the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of...

Descripción completa

Detalles Bibliográficos
Autores principales: Royalty, Jane E, Konradsen, Gitte, Eskerod, Ole, Wulff, Birgitte S, Hansen, Birgit S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Pharmacokinetics/Pharmacodynamics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263154/
https://www.ncbi.nlm.nih.gov/pubmed/24166760
http://dx.doi.org/10.1002/jcph.211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263154/
https://www.ncbi.nlm.nih.gov/pubmed/24166760
http://dx.doi.org/10.1002/jcph.211

Ejemplares similares